Ind-Swift Laboratories Ltd (INDSWFTLAB) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 393806, "name": "Ind-Swift Labs.", "stock_name": "Ind-Swift Labs.", "full_name": "Ind-Swift Laboratories Ltd", "name_url": "stocks-analysis/ind-swift-labs", "exchange": 1, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "187.38", "chg": 18.7, "chgp": "11.09%", "dir": 1, "prev_price": "168.68", "mcapval": "1,522.00 Cr", "mcap": "Micro Cap", "scripcode": 532305, "symbol": "INDSWFTLAB", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE915B01019", "curr_date": "Jun 19, 03:30 PM", "curr_time": "17:30 PM", "last_traded_at": "Jun 19, 03:30 PM IST", "bse_nse_vol": "47.87 lacs", "exc_status": "Active", "traded_date": "Jun 19, 2026", "traded_date_str": "2026 06 19", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ind-swift-labs-393806-1&utm_source=Spage_Header_Score", "mojoone": { "text": "Part of MojoOne Strategy", "type": "MN", "url": "https://www.marketsmojo.com/mojopro/strategy/2", "ismore": 0, "all_data": [], "is_blur": 1, "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ind-swift-labs-393806-1&utm_source=Spage_Score_PartofStrategies" } }, "news": { "results": [ { "title": "Broad-Based Technical Strength Lifts Ind-Swift Laboratories Ltd to 52-Week High of Rs 178.65", "link": "https://www.marketsmojo.com/news/stocks-in-action/ind-swift-laboratories-ltd-hits-new-52-week-high-at-rs17865-4062961", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/IndSwiftLaborat_priceRelatedfactors_4062961.png", "date": "2026-06-19 09:47:44", "description": "With a decisive surge to Rs 178.65 on 19 Jun 2026, Ind-Swift Laboratories Ltd has reached a fresh 52-week high, marking a remarkable 75.53% gain over the past year. This milestone comes amid a backdrop of strong technical momentum that has propelled the stock well above its key moving averages, even as the broader Sensex trades lower." }, { "title": "Ind-Swift Laboratories Gains 3.69%: 3 Key Factors Driving the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/ind-swift-laboratories-gains-369-3-key-factors-driving-the-week-4052933", "imagepath": "", "date": "2026-06-14 11:00:51", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>1 June:</strong> New 52-week high at Rs.166.85</p>\n <p><strong>2 June:</strong> Upgraded to Hold on technical and financial improvements</p>\n <p><strong>2 June:</strong> Bullish momentum shift amid strong technical signals</p>\n <p><strong>5 June:</strong> Week closes at Rs.157.55 (+3.69%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.151.95</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.157.55</div><div class=\"stat-change ..." }, { "title": "Ind-Swift Laboratories Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/ind-swift-laboratories-ltd-is-rated-hold-4050880", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/IndSwiftLaborat_mojoScore_4050880.png", "date": "2026-06-13 10:10:51", "description": "Ind-Swift Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 June 2026, providing investors with the most up-to-date view of the company’s performance and outlook." }, { "title": "Ind-Swift Laboratories Ltd Upgraded to Hold on Technical and Financial Improvements", "link": "https://www.marketsmojo.com/news/stock-recommendation/ind-swift-laboratories-ltd-upgraded-to-hold-on-technical-and-financial-improvements-4030134", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/IndSwiftLaborat_mojoScore_4030134.png", "date": "2026-06-02 08:42:29", "description": "Ind-Swift Laboratories Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in technical indicators and recent financial results. The upgrade, effective from 1 June 2026, is driven by enhanced technical trends, robust quarterly sales growth, and a strong market performance relative to benchmarks, despite lingering concerns over long-term fundamentals and profitability." }, { "title": "Ind-Swift Laboratories Ltd Sees Bullish Momentum Shift Amid Strong Technical Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/ind-swift-laboratories-ltd-sees-bullish-momentum-shift-amid-strong-technical-signals-4029307", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/IndSwiftLaborat_technicaldot_4029307.png", "date": "2026-06-02 08:03:09", "description": "Ind-Swift Laboratories Ltd has witnessed a significant shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underscored by strong weekly and monthly MACD signals, bullish moving averages, and a notable 8.00% gain in a single trading session, signalling renewed investor interest in this micro-cap pharmaceutical player." }, { "title": "Broad-Based Technical Strength Lifts Ind-Swift Laboratories Ltd to 52-Week High of Rs 166.85", "link": "https://www.marketsmojo.com/news/stocks-in-action/ind-swift-laboratories-ltd-hits-new-52-week-high-at-rs16685-4025777", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/IndSwiftLaborat_priceRelatedfactors_4025777.png", "date": "2026-06-01 09:45:51", "description": "With a surge to Rs 166.85 on 1 Jun 2026, Ind-Swift Laboratories Ltd has reached a fresh 52-week high, marking a remarkable 95.55% gain over the past year. This milestone is underpinned by a confluence of technical indicators signalling sustained momentum, even as the broader Sensex trades near its own lows." }, { "title": "Ind-Swift Laboratories Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/ind-swift-laboratories-ltd-is-rated-sell-4024231", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IndSwiftLaborat_mojoScore_4024231.png", "date": "2026-05-31 10:10:42", "description": "Ind-Swift Laboratories Ltd is rated Sell by MarketsMOJO, with this rating last updated on 27 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 May 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Are Ind-Swift Laboratories Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-ind-swift-laboratories-ltd-latest-results-good-or-bad-4023811", "imagepath": "", "date": "2026-05-30 19:44:57", "description": "Ind-Swift Laboratories Ltd's latest financial results for the quarter ended March 2026 reflect notable operational trends. The company reported net sales of ₹169.79 crores, marking a year-on-year growth of 22.82%, which indicates a recovery in demand for its API products. This growth is significant as it contrasts sharply with the previous year's decline of 73.85%. The sequential increase of 12.56% from the previous quarter also suggests a positive momentum in sales.\n\nNet profit for the same quarter stood at ₹15.11 crores, which, while showing a quarter-on-quarter improvement of 58.39%, reflects a substantial year-on-year decline of 93.20%. This decline is largely attributed to the extraordinary items that inflated profits in the prior year, making direct comparisons less meaningful.\n\nThe operational margins exhibited improvement, with the operating margin reaching 12.12%, the highest in the last seven quar..." }, { "title": "Ind-Swift Laboratories Surges 15.16%: Key Drivers Behind the Rally", "link": "https://www.marketsmojo.com/news/stocks-in-action/ind-swift-laboratories-surges-1516-key-drivers-behind-the-rally-4023591", "imagepath": "", "date": "2026-05-30 17:16:04", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>May 25:</strong> Modest gain of 0.08% amid broad market rally</p>\n <p><strong>May 26:</strong> Sharp 2.99% rise despite Sensex decline</p>\n <p><strong>May 27:</strong> Minor pullback of 0.85% on low volume</p>\n <p><strong>May 29:</strong> New 52-week high at Rs.158.15 and strong Q4 FY26 results</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.131.95</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.151.95</div><div class=\"stat-c..." } ], "total": 202, "sid": "393806", "stock_news_url": "https://www.marketsmojo.com/news/ind-swift-laboratories-393806" }, "announcements": [ { "details": "Ind-Swift Laboratories Limited has informed the Exchange regarding 'Prior Intimation under Regulation 50 (1) and 60 (2) of SEBI (Listing Obligations and Disclosure requirements), Regulations, 2015 of Record Date and redemption/Payment of Interest Date'.", "source": "NSE", "caption": "Ind-Swift Laboratories Limited - Updates", "datetime": "09-Dec-2019" }, { "details": " <table><tr><td>Ind-Swift Laboratories Limited has informed the Exchange regarding 'Prior Intimation under Regulations 50(1) and 60(2) of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 of Record date and payment of Interest Date'. </td></tr></table>", "source": "NSE", "caption": "Updates", "datetime": "16-Sep-2019" }, { "details": " <table><tr><td>Ind-Swift Laboratories Limited has informed the Exchange regarding 'Intimation regarding Publication of Notice of 24th AnnualGeneral Meeting of the Company in the Newspaper'. </td></tr></table>", "source": "NSE", "caption": "Updates", "datetime": "09-Sep-2019" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Ind-Swift Laboratories Ltd has declared <strong>10%</strong> dividend, ex-date: 20 Sep 11", "dt": "2011-09-20", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

1 June: New 52-week high at Rs.166.85

2 June: Upgraded to Hold on technical and financial improvements

2 June: Bullish momentum shift amid strong technical signals

5 June: Week closes at Rs.157.55 (+3.69%)

Read full news article

Ind-Swift Laboratories Ltd is Rated Hold

2026-06-13 10:10:51

Ind-Swift Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 June 2026, providing investors with the most up-to-date view of the company’s performance and outlook.

Read full news article

Ind-Swift Laboratories Ltd Upgraded to Hold on Technical and Financial Improvements

2026-06-02 08:42:29

Ind-Swift Laboratories Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in technical indicators and recent financial results. The upgrade, effective from 1 June 2026, is driven by enhanced technical trends, robust quarterly sales growth, and a strong market performance relative to benchmarks, despite lingering concerns over long-term fundamentals and profitability.

Read full news article

Ind-Swift Laboratories Ltd Sees Bullish Momentum Shift Amid Strong Technical Signals

2026-06-02 08:03:09

Ind-Swift Laboratories Ltd has witnessed a significant shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underscored by strong weekly and monthly MACD signals, bullish moving averages, and a notable 8.00% gain in a single trading session, signalling renewed investor interest in this micro-cap pharmaceutical player.

Read full news article

Broad-Based Technical Strength Lifts Ind-Swift Laboratories Ltd to 52-Week High of Rs 166.85

2026-06-01 09:45:51

With a surge to Rs 166.85 on 1 Jun 2026, Ind-Swift Laboratories Ltd has reached a fresh 52-week high, marking a remarkable 95.55% gain over the past year. This milestone is underpinned by a confluence of technical indicators signalling sustained momentum, even as the broader Sensex trades near its own lows.

Read full news article

Ind-Swift Laboratories Ltd is Rated Sell

2026-05-31 10:10:42

Ind-Swift Laboratories Ltd is rated Sell by MarketsMOJO, with this rating last updated on 27 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 May 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Are Ind-Swift Laboratories Ltd latest results good or bad?

2026-05-30 19:44:57

Ind-Swift Laboratories Ltd's latest financial results for the quarter ended March 2026 reflect notable operational trends. The company reported net sales of ₹169.79 crores, marking a year-on-year growth of 22.82%, which indicates a recovery in demand for its API products. This growth is significant as it contrasts sharply with the previous year's decline of 73.85%. The sequential increase of 12.56% from the previous quarter also suggests a positive momentum in sales. Net profit for the same quarter stood at ₹15.11 crores, which, while showing a quarter-on-quarter improvement of 58.39%, reflects a substantial year-on-year decline of 93.20%. This decline is largely attributed to the extraordinary items that inflated profits in the prior year, making direct comparisons less meaningful. The operational margins exhibited improvement, with the operating margin reaching 12.12%, the highest in the last seven quar...